Genolution Inc. (KOSDAQ:225220)
South Korea · Delayed Price · Currency is KRW 2,240.00
+85.00 (3.94%)
At close: Oct 30, 2025
Genolution Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Revenue | 8,767 | 7,136 | 9,761 | 38,085 |
Other Revenue | -0 | -0 | - | -0 |
| 8,767 | 7,136 | 9,761 | 38,085 | |
Revenue Growth (YoY) | 14.43% | -26.90% | -74.37% | - |
Cost of Revenue | 4,915 | 4,836 | 5,304 | 12,177 |
Gross Profit | 3,852 | 2,300 | 4,457 | 25,907 |
Selling, General & Admin | 9,536 | 7,940 | 7,142 | 8,660 |
Research & Development | 932.96 | 1,672 | 3,081 | 1,516 |
Amortization of Goodwill & Intangibles | 45.31 | 42.79 | 32.16 | 22.38 |
Other Operating Expenses | 274.3 | 252.32 | 330.46 | -18.12 |
Operating Expenses | 12,608 | 11,464 | 11,549 | 11,171 |
Operating Income | -8,756 | -9,164 | -7,091 | 14,737 |
Interest Expense | -854.01 | -418.09 | - | -311.61 |
Interest & Investment Income | 1,386 | 1,808 | 1,835 | 665.52 |
Earnings From Equity Investments | - | -103.43 | 382.21 | -144.85 |
Currency Exchange Gain (Loss) | -285.28 | 4,114 | 377.64 | 1,703 |
Other Non Operating Income (Expenses) | 76.8 | 126.9 | 19.02 | 568.26 |
EBT Excluding Unusual Items | -8,432 | -3,637 | -4,477 | 17,217 |
Gain (Loss) on Sale of Investments | -2,957 | -3,118 | 542.13 | -459.01 |
Gain (Loss) on Sale of Assets | -26.48 | - | -2,577 | 218.54 |
Asset Writedown | -12.5 | -17 | -141.55 | - |
Other Unusual Items | - | - | - | 262.4 |
Pretax Income | -11,428 | -6,771 | -6,653 | 17,239 |
Income Tax Expense | -564.23 | 437.36 | -1,103 | 2,637 |
Earnings From Continuing Operations | -10,863 | -7,209 | -5,550 | 14,602 |
Minority Interest in Earnings | 606.66 | 383.22 | 38.75 | - |
Net Income | -10,257 | -6,826 | -5,512 | 14,602 |
Net Income to Common | -10,257 | -6,826 | -5,512 | 14,602 |
Shares Outstanding (Basic) | 18 | 18 | 18 | 18 |
Shares Outstanding (Diluted) | 18 | 18 | 18 | 19 |
Shares Change (YoY) | -0.68% | -1.58% | -2.81% | - |
EPS (Basic) | -567.93 | -378.02 | -300.43 | 800.93 |
EPS (Diluted) | -568.01 | -378.02 | -300.43 | 768.91 |
Free Cash Flow | -10,785 | -13,558 | -7,940 | -8,955 |
Free Cash Flow Per Share | -597.16 | -750.87 | -432.81 | -474.38 |
Gross Margin | 43.94% | 32.23% | 45.66% | 68.03% |
Operating Margin | -99.87% | -128.42% | -72.65% | 38.70% |
Profit Margin | -116.99% | -95.65% | -56.46% | 38.34% |
Free Cash Flow Margin | -123.01% | -190.00% | -81.34% | -23.51% |
EBITDA | -6,389 | -7,123 | -5,513 | 16,065 |
EBITDA Margin | -72.87% | -99.82% | -56.48% | 42.18% |
D&A For EBITDA | 2,366 | 2,041 | 1,578 | 1,328 |
EBIT | -8,756 | -9,164 | -7,091 | 14,737 |
EBIT Margin | -99.87% | -128.42% | -72.65% | 38.70% |
Effective Tax Rate | - | - | - | 15.30% |
Advertising Expenses | - | 470.47 | 343.49 | 435.03 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.